Cargando…

Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up

Purpose. To report the long-term follow-up results in patients with cataract and primary open-angle glaucoma (POAG) randomly assigned to cataract surgery combined with micro-bypass stent implantation or phacoemulsification alone. Methods. 36 subjects with cataract and POAG were randomized in a 1 : 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Fea, Antonio Maria, Consolandi, Giulia, Zola, Marta, Pignata, Giulia, Cannizzo, Paola, Lavia, Carlo, Rolle, Teresa, Grignolo, Federico Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637500/
https://www.ncbi.nlm.nih.gov/pubmed/26587282
http://dx.doi.org/10.1155/2015/795357
_version_ 1782399828267892736
author Fea, Antonio Maria
Consolandi, Giulia
Zola, Marta
Pignata, Giulia
Cannizzo, Paola
Lavia, Carlo
Rolle, Teresa
Grignolo, Federico Maria
author_facet Fea, Antonio Maria
Consolandi, Giulia
Zola, Marta
Pignata, Giulia
Cannizzo, Paola
Lavia, Carlo
Rolle, Teresa
Grignolo, Federico Maria
author_sort Fea, Antonio Maria
collection PubMed
description Purpose. To report the long-term follow-up results in patients with cataract and primary open-angle glaucoma (POAG) randomly assigned to cataract surgery combined with micro-bypass stent implantation or phacoemulsification alone. Methods. 36 subjects with cataract and POAG were randomized in a 1 : 2 ratio to either iStent implantation and cataract surgery (combined group) or cataract surgery alone (control group). 24 subjects agreed to be evaluated again 48 months after surgery. Patients returned one month later for unmedicated washout assessment. Results. At the long-term follow-up visit we reported a mean IOP of 15,9 ± 2,3 mmHg in the iStent group and 17 ± 2,5 mmHg in the control group (p = NS). After washout, a 14,2% between group difference in favour of the combined group was statistically significant (p = 0,02) for mean IOP reduction. A significant reduction in the mean number of medications was observed in both groups compared to baseline values (p = 0,005 in the combined group and p = 0,01 in the control group). Conclusion. Patients in the combined group maintained low IOP levels after long-term follow-up. Cataract surgery alone showed a loss of efficacy in controlling IOP over time. Both treatments reduced the number of ocular hypotensive medications prescribed. This trial is registered with: NCT00847158.
format Online
Article
Text
id pubmed-4637500
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46375002015-11-19 Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up Fea, Antonio Maria Consolandi, Giulia Zola, Marta Pignata, Giulia Cannizzo, Paola Lavia, Carlo Rolle, Teresa Grignolo, Federico Maria J Ophthalmol Clinical Study Purpose. To report the long-term follow-up results in patients with cataract and primary open-angle glaucoma (POAG) randomly assigned to cataract surgery combined with micro-bypass stent implantation or phacoemulsification alone. Methods. 36 subjects with cataract and POAG were randomized in a 1 : 2 ratio to either iStent implantation and cataract surgery (combined group) or cataract surgery alone (control group). 24 subjects agreed to be evaluated again 48 months after surgery. Patients returned one month later for unmedicated washout assessment. Results. At the long-term follow-up visit we reported a mean IOP of 15,9 ± 2,3 mmHg in the iStent group and 17 ± 2,5 mmHg in the control group (p = NS). After washout, a 14,2% between group difference in favour of the combined group was statistically significant (p = 0,02) for mean IOP reduction. A significant reduction in the mean number of medications was observed in both groups compared to baseline values (p = 0,005 in the combined group and p = 0,01 in the control group). Conclusion. Patients in the combined group maintained low IOP levels after long-term follow-up. Cataract surgery alone showed a loss of efficacy in controlling IOP over time. Both treatments reduced the number of ocular hypotensive medications prescribed. This trial is registered with: NCT00847158. Hindawi Publishing Corporation 2015 2015-10-26 /pmc/articles/PMC4637500/ /pubmed/26587282 http://dx.doi.org/10.1155/2015/795357 Text en Copyright © 2015 Antonio Maria Fea et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Fea, Antonio Maria
Consolandi, Giulia
Zola, Marta
Pignata, Giulia
Cannizzo, Paola
Lavia, Carlo
Rolle, Teresa
Grignolo, Federico Maria
Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
title Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
title_full Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
title_fullStr Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
title_full_unstemmed Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
title_short Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up
title_sort micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637500/
https://www.ncbi.nlm.nih.gov/pubmed/26587282
http://dx.doi.org/10.1155/2015/795357
work_keys_str_mv AT feaantoniomaria microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT consolandigiulia microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT zolamarta microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT pignatagiulia microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT cannizzopaola microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT laviacarlo microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT rolleteresa microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup
AT grignolofedericomaria microbypassimplantationforprimaryopenangleglaucomacombinedwithphacoemulsification4yearfollowup